Stoneridge Investment Partners LLC Gilead Sciences, Inc. Transaction History

Stoneridge Investment Partners LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 30, 2021	SELL	$60.0 - $68.46 $465,960 - $531,660	-7,766 Closed	0 $0
Q4 2020 Feb 02, 2021	SELL	$56.65 - $64.55 $11,330 - $12,910	-200 Reduced 2.51%	7,766 $452,000
Q3 2020 Oct 28, 2020	SELL	$62.1 - $78.08 $1.34 Million - $1.69 Million	-21,641 Reduced 73.09%	7,966 $503,000
Q2 2020 Aug 05, 2020	BUY	$72.34 - $84.0 $2.14 Million - $2.49 Million	29,607 New	29,607 $2.28 Million
Q1 2020 May 05, 2020	SELL	$62.63 - $80.22 $3.28 Million - $4.21 Million	-52,420 Closed	0 $0
Q4 2019 Jan 29, 2020	SELL	$61.62 - $67.78 $859,660 - $945,598	-13,951 Reduced 21.02%	52,420 $3.41 Million
Q3 2019 Oct 30, 2019	SELL	$62.51 - $69.0 $1.55 Million - $1.71 Million	-24,794 Reduced 27.2%	66,371 $4.21 Million
Q2 2019 Jul 29, 2019	BUY	$61.87 - $69.38 $498,610 - $559,133	8,059 Added 9.7%	91,165 $6.16 Million
Q1 2019 Apr 25, 2019	BUY	$62.53 - $70.05 $5.2 Million - $5.82 Million	83,106 New	83,106 $5.4 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Stoneridge Investment Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Stoneridge Investment Partners LLC with notifications on news.